|
Eye Sight and Health
Enzogenol improves distant vision
and slows down the decline in eye function
Eye
sight deteriorates with age. Good nutrition and appropriate supplementation can prevent and or slow down this decline.
Clinical research with Enzogenol has shown a significant
improvement in vision and less deterioration demonstrating that
Enzogenol may improve distant vision and slow down the decline
of eye function with age.
Improving Eye Sight
This study with 60 residents from a retirement home and with an average age of 82 years showed that
Enzogenol may help to improve eye sight. Distant vision improved
significantly over the control group who were taking vitamin C only. There were less
people experiencing deterioration, and more people with stable and
improved vision.
Improvement In Distant Vision
There was a
significant improvement in distant vision and the deterioration in acuity
of vision was five times less with Enzogenol than with Vitamin C alone
demonstrating that Enzogenol may help vision and may reduce the
deterioration in eye sight that is a normal consequence of getting older.
Loss In Vision Acuity
A combined
measure of near and distant vision declined five times faster in the
control group compared to the Enzogenol group over the 6 months trial
period.
Conclusion
 Interestingly, there were less cases of illness (adverse and serious
adverse events) in the Enzogenol group than in the control group which
possibly reflected better overall health of the elderly people taking
Enzogenol. These findings showed that taking Enzogenol had benefits for people’s eye
sight. In particular, these benefits were effective in a population of
older people that commonly experience difficulties with their eye sight.
Med Note
This study
was carried out by Rachel March and Dr. Nigel Gilchrist of the
Christchurch Geriatric Medical Research Trust at the Princess Margaret
Hospital, Christchurch, New Zealand. In this trial 60 participants from
local rest-homes with an average age of 82 years were assigned to
treatment and control groups. The 30 treatment subjects received 480 mg of
Enzogenol + 60 mg of Vitamin C per day for 6 months. The 30 control
subjects received 60 mg of Vitamin C only. In this third clinical trial
Enzogenol was again very well tolerated with no treatment related adverse
reactions and normal laboratory measures of all biochemical and
haematological parameters. The data indicated that Enzogenol was
associated with beneficial effects for eye function shown. Publication is in progress.
Top of page
|
